| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $1.41M | $5.57M | $713.23K | $323.94K | $681.94K |
| R&D | – | – | – | – | – |
| SG&A | $1.41M | $992.14K | $593.99K | $323.94K | $681.94K |
| Operating Income | -$1.41M | -$5.57M | -$713.23K | -$323.94K | -$681.94K |
| Interest Expense | – | – | – | $752.23K | $680.55K |
| Tax Expense | – | – | – | – | – |
| Net Income | -$1.92M | -$5.93M | -$1.29M | -$1.05M | -$1.13M |
| EPS (basic) | -0.1400 | -0.4300 | -0.2300 | -0.3900 | -0.4200 |
| EPS (diluted) | -0.1400 | -0.4300 | – | – | – |
| Shares (diluted) | $13.75M | $13.91M | – | – | – |